Aprotinin and the systemic inflammatory response after cardiopulmonary bypass
- 1 February 2001
- journal article
- review article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 71 (2) , 745-754
- https://doi.org/10.1016/s0003-4975(00)02218-9
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- AprotininDrugs, 1999
- Aprotinin Reduces the Expression of P‐Selectin on the Surface of Platelet and Leukocyte‐Platelet ConjugatesArtificial Organs, 1998
- Aprotinin Reduces Interleukin-8 Production and Lung Neutrophil Accumulation After Cardiopulmonary BypassAnesthesia & Analgesia, 1996
- Aprotinin® diminishes inflammatory processesInternational Journal of Cardiology, 1996
- Preventing the inflammatory response to open-heart surgery: The role of aprotinin and other protease inhibitorsInternational Journal of Cardiology, 1996
- Blood contact activation: pathophysiological effects and therapeutic approachesPerfusion, 1996
- Systemic inflammation during paediatric cardiopulmonary bypass: changes in neutrophil adhesive propertiesPerfusion, 1993
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Inhibition of kinin formation by a kallikrein inhibitor during extracorporeal circulation in open-heart surgery.Circulation, 1975
- Studies in Extracorporeal Circulation. I. Applicability of Gibbon-Type Pump-Oxygenator to Human Intracardiac SurgeryAnnals of Surgery, 1956